Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients
Clinical trial NCT00002234 · COMPLETED
Trial details
- NCT number
- NCT00002234
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.